See All Slides - tctmd.com

Slides

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

Possible Solutions

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

Allogeneic Cardiac-Derived Cells for STEMI

Presenter: Raj Makkar

October 29, 2013

Presentation

Coronary Calcification: Insights from Angiography, IVUS, and OCT

Presenter: Gary Mintz

October 29, 2013

Presentation

From Rotational to Orbital Atherectomy

Presenter: Jeffrey Chambers

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

How Did I Treat?(2)

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

PCI vs CABG: Wait a Minute! These Lesions Need to Be Physiologically Evaluated Before Choosing Either!

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Advertisement

Slides

Silent Atrial Fibrillation: An Under-Appreciated Threat

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Possible Solutions

Allogeneic Cardiac-Derived Cells for STEMI

Coronary Calcification: Insights from Angiography, IVUS, and OCT

From Rotational to Orbital Atherectomy

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

How Did I Treat?(2)

PCI vs CABG: Wait a Minute! These Lesions Need to Be Physiologically Evaluated Before Choosing Either!

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content